Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 465
Immune Disorders Drugs 196
Cardiovascular Drugs 154
Biopharmaceuticals 132
Infectious Diseases Drugs 121
Central Nervous System Drugs 104
Endocrine and Metabolic Disorders Drugs 103
Drug Discovery 102
Musculoskeletal Disorders Drugs 94
Clinical Trials 90
Pharmaceuticals 88
Leukemia Drugs 83
Hematological Drugs 83
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 64
Dermatological Drugs 59
Diabetes Drugs 54
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Infusions and Injectables 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Antibiotics 23
Kidney Cancer Drugs 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Uterine Cancer Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



284 reviews

2,388 Results (Page 15 of 120)
- Relevance
  Sort by

Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1588 Pages
Global

From

€2237EUR$2,500USD£1,913GBP

Colon Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
746 Pages
Global

From

€2237EUR$2,500USD£1,913GBP

Ependymoma Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
94 Pages
Global

From

€3500EUR$4,190USD£3,098GBP

Hepatocellular Carcinoma Treatment Market Forecast- Epidemiology & Pipeline Analysis 2022-2027

 Report
January 2023
189 Pages
Global

From

€3758EUR$4,200USD£3,214GBP

Paracetamol IV - Global Strategic Business Report

 Report
August 2026
374 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Melanoma Therapeutics Market Size, Share & Trends Analysis Report By Product (Chemotherapy, Immunotherapy), By Drug Type (Branded Drugs, Generic Drugs), By Region, And Segment Forecasts, 2023 - 2030

 Report
September 2023
100 Pages
Global

From

€5324EUR$5,950USD£4,553GBP

Antibacterial Drugs Market 2026-2030

 Report
August 2026
313 Pages
Global

From

€2237EUR$2,500USD£1,913GBP

Non-melanoma Skin Cancer Market 2024-2028

 Report
July 2024
145 Pages
Global

From

€2237EUR$2,500USD£1,913GBP

Antibody Drug Conjugate (ADC) Technology Market Industry Trends and Global Forecasts to 2035, by Generation of Technology, Type of Conjugation, Type of Linker, Type of Payment Model Adopted and Key Geographical Regions

 Report
March 2025
407 Pages
Global

From

€4294EUR$4,799USD£3,672GBP

Sickle Cell Disease Treatment - Global Strategic Business Report

 Report
August 2026
148 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Antithrombotic Drugs Market - Global Strategic Business Report

 Report
August 2026
282 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Sickle-Cell Anemia Therapeutics - Global Strategic Business Report

 Report
August 2026
181 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Hematological Malignancies - Global Strategic Business Report

 Report
August 2026
193 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Lipid Nanoparticles in Drug Delivery: Intellectual Property Landscape

 Report
March 2023
182 Pages
Global

From

€1699EUR$1,899USD£1,453GBP

Bispecific Antibodies Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Therapeutic Area, Mechanism of Action, Target Antigen Antibody Format, Key Geographical Regions and Key Players

 Report
December 2025
391 Pages
Global

From

€4294EUR$4,799USD£3,672GBP

Clobetasol Propionate API Market - Global Forecast to 2030

 Report
August 2025
182 Pages
Global

From

€3172EUR$3,545USD£2,713GBP

€3524EUR$3,939USD£3,014GBP

Non-Small Cell Lung Cancer Market by Type, Treatment Type, Distribution Channel, and Geography: Forecast up to 2027

 Report
July 2023
223 Pages
Global

From

€4026EUR$4,500USD£3,443GBP

Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1036 Pages
Global

From

€2237EUR$2,500USD£1,913GBP

Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
143 Pages
Global

From

€1790EUR$2,000USD£1,530GBP

Anti-Asthmatics and COPD Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4017EUR$4,490USD£3,436GBP

2,388 Results (Page 15 of 120)
- 1
- 13
- 14
- 15
- 16
- 17

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.